Clemens Wittenbecher

Clemens Wittenbecher

DDLS Fellow, Chalmers University of Technology

Key Publications
Plasma Metabolome, Long-term Body Weight Change, and Type 2 Diabetes in U.S. Individuals
Diabetes Care, 2025
Precision nutrition for cardiometabolic diseases
Nature Medicine, 2025
A genome-wide association study in 10,000 individuals links plasma N-glycome to liver disease and anti-inflammatory proteins
NATURE COMMUNICATIONS, 2025
ApoB-containing lipoproteins: count, type, size, and risk of coronary artery disease
EUROPEAN HEART JOURNAL, 2025
Omics Approach for Personalised Prevention of Type 2 Diabetes Mellitus for African and European Populations (OPTIMA): a protocol paper
BMJ OPEN, 2025

Clemens Wittenbecher

Our research group is dedicated to pioneering precision nutrition strategies with the goal of effectively mitigating cardiometabolic disease risk through targeted dietary approaches. Harnessing our expertise in nutrition, epidemiology, metabolomics, and bioinformatics, we integrate -omics profiles to identify the biological process that play a critical role as mediators and modifiers in the nexus between diet and disease risk.

We primarily work with large-scale human population and dietary intervention studies. Our endeavors aim to develop biomarkers and computational methodologies to pinpoint population segments that are particularly vulnerable to the negative effects of specific foods or dietary patterns. Through this, we aspire to shape precision nutrition strategies for dietary risk prevention.

Group Members

Nuria Estanyol-Torres
Cecilia Martinez Escobedo
Hui Li

Last updated: 2025-12-04

Content Responsible: David Gotthold(david.gotthold@scilifelab.se)